Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China flag China · Delayed Price · Currency is CNY
18.08
+0.92 (5.36%)
Feb 3, 2026, 3:04 PM CST

SHE:300401 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,2411,2841,503554.91502.091,161
Trading Asset Securities
300.98140.25--0.4200
Cash & Short-Term Investments
1,5421,4251,503554.91502.491,361
Cash Growth
8.02%-5.20%170.83%10.43%-63.08%124.67%
Accounts Receivable
235.66157.7492.78169.6690.4674.41
Other Receivables
4.070.730.81.210.411.55
Receivables
239.73158.4793.57170.8790.8775.96
Inventory
744.1838.23780.04545.87429.94319.9
Other Current Assets
37.2347.9985.56115.3788.0739.28
Total Current Assets
2,5632,4692,4621,3871,1111,796
Property, Plant & Equipment
2,9712,7872,4552,4322,1191,418
Other Intangible Assets
216.17182.73172.23165.77165.87180.17
Long-Term Accounts Receivable
-0.03----
Long-Term Deferred Tax Assets
31.9136.2740.4119.7611.5121.87
Long-Term Deferred Charges
53.9626.5224.5225.4616.617.44
Other Long-Term Assets
77.56110.86106.01101.97105.67146.19
Total Assets
5,9135,6135,2614,1323,5303,570
Accounts Payable
336.04340.54327.87443.02329.59158.64
Accrued Expenses
28.4963.1450.4260.8347.2136.23
Short-Term Debt
594.27462.79408.68532.39414.37240.36
Current Portion of Long-Term Debt
-198.16254.51---
Current Portion of Leases
-0.1--0.2-
Current Income Taxes Payable
32.2223.4116.5618.515.3210.99
Current Unearned Revenue
11.1321.2619.5555.0334.879.45
Other Current Liabilities
242.83165.27186.08199.2956.78122.99
Total Current Liabilities
1,2451,2751,2641,309898.34578.65
Long-Term Debt
1,1831,054923.27---
Long-Term Unearned Revenue
28.5230.3342.5263.668.86112.15
Long-Term Deferred Tax Liabilities
38.5334.9944.660.370.06-
Other Long-Term Liabilities
--93.33186.66279.99-
Total Liabilities
2,4952,3942,3671,5601,247690.8
Common Stock
543.47543.47551.01551.01551.01551.01
Additional Paid-In Capital
----21,031
Retained Earnings
2,6692,4972,2262,1111,8301,403
Treasury Stock
--26.86-140.42-53.72-100-100
Comprehensive Income & Other
205.5204.58256.07-36.37--
Total Common Equity
3,4183,2182,8932,5722,2832,885
Minority Interest
-0.01-0----6.23
Shareholders' Equity
3,4183,2182,8932,5722,2832,879
Total Liabilities & Equity
5,9135,6135,2614,1323,5303,570
Total Debt
1,7771,7151,586532.39414.57240.36
Net Cash (Debt)
-235.74-290.6-83.5922.5287.931,121
Net Cash Growth
----74.39%-92.15%219.47%
Net Cash Per Share
-0.41-0.49-0.140.040.162.21
Filing Date Shares Outstanding
543.47534.68542.23559.82543.33543.33
Total Common Shares Outstanding
543.47534.68542.23559.82543.33543.33
Working Capital
1,3181,1951,19877.97213.041,217
Book Value Per Share
6.296.025.344.594.205.31
Tangible Book Value
3,2023,0362,7212,4062,1172,705
Tangible Book Value Per Share
5.895.685.024.303.904.98
Buildings
-1,4731,3771,180490.73377.95
Machinery
-1,149938.79844.74360.6327.79
Construction In Progress
-661.13504.59672.131,479991.11
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.